AIM
TMO icon

Acropolis Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Acropolis Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$146K Sell
217
-4
-2% -$2.38K 0.01% 325
2026
Q2 		$111K Buy
221
+4
+2% +$1.92K ﹤0.01% 367
2026
Q1 		$107K Buy
+217
New +$118K ﹤0.01% 367

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Acropolis Investment Management's TMO Position: Q3 2026 in Review

Acropolis Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q3 2026, selling an estimated $2.38K and leaving 217 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #325.

Acropolis Investment Management first reported a position in TMO in Q1 2026 and has held it in 3 quarters since. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Acropolis Investment Management held 217 shares of Thermo Fisher Scientific worth $146K as of Q3 2026.
  • Acropolis Investment Management sold 4 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.38K.
  • Thermo Fisher Scientific made up 0.01% of Acropolis Investment Management's portfolio in Q3 2026, its #325 holding.
  • Acropolis Investment Management first reported a position in Thermo Fisher Scientific in Q1 2026 and has held it in 3 quarters since.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Acropolis Investment Management's 13F filing for Q3 2026, filed 8 Oct 2026.